- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02060643
A Cross-sectional Study Looking at the Effect of Radiotherapy on Carotid Intima-medial Thickness in Head and Neck Cancer
Some patients with head and neck cancer or benign tumours of the head and neck receive radiotherapy to their neck as part of their treatment. The carotid arteries are often included in the radiotherapy as collateral structures. There is some evidence to show that radiotherapy to these blood vessels can result in thickening of the artery walls some years after treatment and increased risk of stroke or TIA in the future.
Current research is now aimed towards detecting radiotherapy-related changes to the carotid arteries at an earlier stage and towards using new radiotherapy techniques to avoid treating these blood vessels if possible. The question of whether or not the use of preventive medicines like aspirin and cholesterol-lowering tablets helps to reverse this process is currently unanswered.
The aim of this study is to measure the thickness (intima-medial thickness) of irradiated carotid artery walls and compare this to unirradiated arteries. There are many other causes for thickening of arteries (such as high blood pressure, high cholesterol levels and diabetes) and these may affect the ability to measure the effect of radiotherapy change to the artery wall. In order to address this, it is ideal to look at this process in patients who have only had one side of their neck treated and use the other side as a comparison. The study will also be looking for earlier signs of radiotherapy-related changes, such as stiffening of the artery wall, inflammation in the artery wall (a very early sign of radiotherapy-related change) and some markers in the blood that may indicate that this process is taking place.
The null hypotheses of this study are:
- In irradiated carotid arteries, the mean intimal-medial thickness will be the same compared to unirradiated arteries.
- Serum biomarkers will not be elevated in radiation-induced carotid atherosclerosis.
- Development of radiation-induced carotid atherosclerosis is not affected by risk factor modulation (Aspirin, HMGCoA reductase inhibitors, smoking cessation).
- There is no difference in carotid arterial wall strain in irradiated carotid arteries versus unirradiated carotid arteries.
- Microbubble ultrasound will not be able to detect Inflammation in the carotid arteries as an early marker of atherosclerosis.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Réel)
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Be 18 years or older
- Histologically confirmed cancer or benign tumours of the head and neck area treated with hemi-neck radiotherapy to ≥ 50Gy
- Received radiotherapy to the neck area more than 24 months previously
- Intervening neck dissection allowed
- Be able to provide written informed consent
Exclusion Criteria:
- Patients who have active head and neck cancer
- Patients with a prior history of carotid endarterectomy or carotid angioplasty and stenting
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
---|
Cross-sectional hemi-neck RT
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
The difference in mean IMT between irradiated and unirradiated carotid arteries.
Délai: >2 years post-radiotherapy
|
Cross-sectional study - measured at one time-point at least 2 years after radiotherapy
|
>2 years post-radiotherapy
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
The prevalence of carotid artery stenosis in irradiated carotid arteries compared to unirradiated carotid arteries.
Délai: >2 years post-radiotherapy
|
Cross-sectional - measured at one time point at least 2 years after radiotherapy
|
>2 years post-radiotherapy
|
Quantify the use of risk-modifying therapy (anti-hypertensives, anti-diabetic medication, HMGCoA reductase inhibitors, smoking cessation) and their effect on radiation-induced carotid atherosclerosis.
Délai: > 2 years post-radiotherapy
|
Cross-sectional - measured at one time point at least 2 years after radiotherapy
|
> 2 years post-radiotherapy
|
Correlation of serum biomarker levels to carotid IMT and strain.
Délai: > 2 years post-radiotherapy
|
Cross-sectional - measured at one time point at least 2 years after radiotherapy
|
> 2 years post-radiotherapy
|
The difference in arterial wall strain between irradiated and unirradiated carotid arteries
Délai: > 2 years post-radiotherapy
|
Cross-sectional - measured at least 2 years after radiotherapy
|
> 2 years post-radiotherapy
|
The difference in arterial wall inflammation between irradiated and unirradiated carotid arteries
Délai: > 2 years post-radiotherapy
|
Cross-sectional - measured at one time point at least 2 years after radiotherapy
|
> 2 years post-radiotherapy
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Christopher M Nutting, PhD, Royal Marsden NHS Foundation Trust
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CCR 3687
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Tumeurs de la tête et du cou
-
Mathematica Policy Research, Inc.Boston Children's Hospital; Department of Health and Human ServicesPas encore de recrutementIntervention précoce, éducation (Head Start et Early Head Start Access and Participation)États-Unis
-
Novartis PharmaceuticalsActif, ne recrute pasAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MélanomeTaïwan, États-Unis, Pays-Bas, Espagne, Corée, République de, Italie, Japon, Canada, Singapour